MIR3167

Across TCGA pan-cancer cohorts, MIR3167 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR3167 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR3167 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3167 expression acts as an unfavorable survival marker, although some lineages such as LGG show a favorable association.

MESO, ESCA, and CHOL are the cancer types where MIR3167 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.168	0.579	<.001	126	view →
ESCA	OS	Tertile	II,III,IV	0.102	0.703	<.001	108	view →
CHOL	DFS	Tertile	II,III,IV	0.016	0.406	<.001	72	view →
KIRC	DFS	Tertile	All	0.153	0.627	.009	18	view →
BRCA	DFS	Tertile	All	0.713	0.904	.003	18	view →
STAD	OS	Tertile	All	0.401	0.673	.011	18	view →
UCEC	OS	Tertile	II,III,IV	0.198	0.768	.037	18	view →
PCPG	OS	Tertile	All	0.670	0.945	.008	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →
LGG	DFS	Tertile	All	1.000	0.826	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR3167–MESO (OS)

Open the MESO breakdown →